# DESCRIPTION

## BACKGROUND

- motivate need for improved melanoma therapies

## SUMMARY

- introduce palladium hyaluronic acid particles
- describe methods of managing cancer
- describe pharmaceutical compositions
- describe particle compositions and uses
- describe process of making particles
- describe pharmaceutical compositions and forms
- describe methods of treating or preventing cancer
- describe medicament production

## DETAILED DISCUSSION

- clarify scope of disclosure
- define terminology
- describe incorporation of references
- outline individual embodiments
- define subject and cancer
- define chemotherapy agent
- define prevent and treating
- define combination with
- describe hyaluronic acid
- define dibenzylideneacetone palladium
- describe homogenizer
- define lipid group
- define linking group
- define angiogenic disease and related terms

### Palladium Based Nanoparticles for the Treatment of Cancer and Related Conditions

- introduce Tris DBA-Pd and its activity against NMT1
- summarize efficacy against various cancers
- motivate overcoming poor solubility of Tris DBA-Pd
- describe incorporation into targeted hyaluronic acid-based nanoparticles
- explain targeting of CD44 and IGFR1
- outline methods of treating or preventing cancer or angiogenic conditions
- specify administration of palladium hyaluronic acid particles
- detail treatment of subjects diagnosed with cancer cells expressing CD44 or CD44v
- list specific CD44v isoforms for treatment
- describe measuring increased levels of CD44s or CD44v in cancer cells
- outline diagnosis and treatment of subjects with various cancers
- specify administration of palladium hyaluronic acid particles in combination with other therapeutic agents
- describe use of palladium hyaluronic acid particles for treating neoplasms
- outline method for treating susceptible neoplasm with activating BRAF mutation
- specify analysis of BRAF mutation and administration of palladium hyaluronic acid particles
- introduce palladium based nanoparticles for cancer treatment
- specify neoplasm types
- describe sample sources for BRAF mutation analysis
- outline methods for BRAF mutation detection
- discuss therapeutically effective amount of palladium hyaluronic acid particles
- list factors affecting particle dose
- describe combination therapies with palladium hyaluronic acid particles
- outline methods of treatment and uses
- discuss pharmaceutical compositions with palladium hyaluronic acid particles
- describe concomitant or sequential administration of particles with other therapies
- list anti-neoplastic agents for combination therapy
- describe alkylating agents
- describe antimetabolite neoplastic agents
- describe antitumor antibiotic agents
- describe antimicrotubule or antimitotic agents
- describe topoisomerase inhibitors
- describe hormones and hormonal analogues
- describe retinoids
- list specific cancers and conditions treatable with palladium hyaluronic acid particles

### Pharmaceutical Compositions

- define pharmaceutical composition
- describe forms of pharmaceutical composition
- list pharmaceutically acceptable excipients
- describe enteric coatings
- outline administration methods
- describe compositions for parenteral injection
- describe solid dosage forms
- describe liquid dosage forms
- describe compositions for topical administration

## EXAMPLES

### Formulation of DBA Platinum Nanoparticles

- formulate hyaluronic acid nanoparticles with Tris DBA-Pd

### Palladium Based Nanoparticles for the Treatment of Advanced Melanoma

- synthesize Tris DBA-Pd loaded nanoparticles with and without antibodies to IGF1R
- verify encapsulation of Tris DBA-Pd by HPLC
- evaluate efficacy of Tris DBA-Pd nanoparticles in inhibiting tumor growth
- perform immunohistochemistry to assess expression of target genes
- analyze gene expression using gene arrays
- discuss results and implications for cancer treatment

### In Vivo Studies

- conduct in vivo studies of Tris DBA-Pd nanoparticles in mice with melanoma

### Gene Array and Whole-Transcriptome Expression Analysis.

- perform gene array and whole-transcriptome expression analysis

